Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 16 studies | 33% ± 11% | |
lung | 14 studies | 32% ± 15% | |
kidney | 8 studies | 26% ± 5% | |
intestine | 8 studies | 30% ± 12% | |
eye | 6 studies | 24% ± 4% | |
brain | 6 studies | 23% ± 4% | |
bone marrow | 5 studies | 25% ± 6% | |
liver | 5 studies | 31% ± 14% | |
pancreas | 4 studies | 32% ± 12% | |
placenta | 4 studies | 20% ± 4% | |
uterus | 4 studies | 39% ± 15% | |
lymph node | 4 studies | 30% ± 7% | |
breast | 4 studies | 24% ± 3% | |
esophagus | 3 studies | 37% ± 23% | |
thymus | 3 studies | 37% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1102.14 | 1445 / 1445 | 100% | 17.95 | 183 / 183 |
ovary | 100% | 1320.33 | 180 / 180 | 100% | 26.33 | 430 / 430 |
uterus | 100% | 1221.14 | 170 / 170 | 100% | 14.60 | 459 / 459 |
breast | 100% | 1356.89 | 459 / 459 | 100% | 17.08 | 1116 / 1118 |
bladder | 100% | 1164.00 | 21 / 21 | 100% | 16.81 | 503 / 504 |
lung | 100% | 940.33 | 577 / 578 | 100% | 15.71 | 1154 / 1155 |
prostate | 100% | 1155.02 | 245 / 245 | 99% | 14.09 | 499 / 502 |
stomach | 100% | 1217.34 | 359 / 359 | 99% | 18.63 | 284 / 286 |
pancreas | 100% | 950.91 | 328 / 328 | 99% | 12.60 | 176 / 178 |
thymus | 100% | 1155.13 | 653 / 653 | 99% | 11.88 | 597 / 605 |
brain | 99% | 550.47 | 2624 / 2642 | 99% | 9.83 | 699 / 705 |
intestine | 100% | 1188.72 | 966 / 966 | 98% | 15.83 | 518 / 527 |
adrenal gland | 100% | 1025.74 | 258 / 258 | 97% | 9.46 | 224 / 230 |
liver | 100% | 642.15 | 225 / 226 | 97% | 12.59 | 395 / 406 |
kidney | 100% | 979.92 | 89 / 89 | 96% | 10.32 | 867 / 901 |
skin | 100% | 1058.02 | 1809 / 1809 | 91% | 9.39 | 430 / 472 |
adipose | 100% | 1183.20 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 15.39 | 29 / 29 |
spleen | 100% | 1253.75 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 11.79 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 18.03 | 1 / 1 |
blood vessel | 100% | 1133.70 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 99% | 671.60 | 798 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 863.21 | 854 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 96% | 15.46 | 77 / 80 |
peripheral blood | 46% | 534.67 | 428 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0042254 | Biological process | ribosome biogenesis |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005730 | Cellular component | nucleolus |
Gene name | RBIS |
Protein name | Ribosomal biogenesis factor |
Synonyms | C8orf59 |
Description | FUNCTION: Trans-acting factor in ribosome biogenesis required for efficient 40S and 60S subunit production. . |
Accessions | Q8N0T1 ENST00000611854.4 [Q8N0T1-1] ENST00000614462.4 ENST00000612977.4 [Q8N0T1-1] ENST00000615697.4 [Q8N0T1-1] ENST00000612809.4 [Q8N0T1-1] ENST00000523281.5 E5RGR5 ENST00000545322.5 A0A087WWE7 ENST00000619594.5 [Q8N0T1-1] ENST00000321777.5 [Q8N0T1-2] |